We came across a bullish thesis on Gilead Sciences, Inc. (NASDAQ:GILD) on Substack by Magnus Ofstad. In this article, we will ...

Adv. Dr. Eyal Bressler will head the patents practice at APM. Following the merger, the intellectual property services that ...

With cases of Feline Infectious Peritonitis (FIP) on rise in China, cat owners are making their pets pop in Covid-19 drugs as antidotes. But is it safe, and why are they doing so?

The Triad for Travel Success in 2025 Opinion 0 0 Steve Sitto, Gilead Sciences Global Head of Travel, Meetings & Events 26017 ...

The most recent trading session ended with Gilead Sciences (GILD) standing at $91.41, reflecting a -0.51% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500 ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

BofA Securities has recently resumed Gilead Sciences Inc (GILD) stock to Buy rating, as announced on December 10, 2024, according to Finviz. Earlier, on November 15, 2024, Wolfe Research had initiated ...

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

New research led by scientists at La Jolla Institute for Immunology (LJI) suggests that many people already have immune cells on “stand by” to fight the H5N1 virus, also known as highly pathogenic ...

When children receive their second measles-mumps-rubella vaccine, around the time they start kindergarten, they gain protection against all three viruses for all or most of their lives.